AtriCure (ATRC) Revenue (2010 - 2026)

AtriCure (ATRC) has 17 years of Revenue data on file, last reported at $141.2 million in Q1 2026.

• On a quarterly basis, Revenue rose 14.26% year-over-year to $141.2 million in Q1 2026; TTM through Mar 2026 was $552.2 million, a 15.01% increase from a year earlier, with the FY2025 full-year figure at $534.5 million, up 14.88% from the prior year.
• Revenue for Q1 2026 stood at $141.2 million, up from $140.5 million in the prior quarter.
• Over the last five years, Revenue for ATRC reached as high as $141.2 million in Q1 2026 and fell as low as $74.6 million in Q1 2022.
• Historically, Revenue has averaged $110.0 million across 5 years, with a median of $108.9 million in 2024.
• Across the five-year window, Revenue increased 25.81% in 2022 and grew 13.05% in 2025, its largest moves.
• Year by year, Revenue stood at $88.0 million in 2022, then gained by 21.03% to $106.5 million in 2023, then advanced by 16.64% to $124.3 million in 2024, then rose by 13.05% to $140.5 million in 2025, then gained by 0.53% to $141.2 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $141.2 million in Q1 2026, $140.5 million in Q4 2025, and $134.3 million in Q3 2025.